Long COVID, a debilitating condition following SARS-CoV-2 infection, continues to disable tens of millions of people globally ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Clearsense®, a cloud-based data enablement platform company, has unveiled a transformative brand repositioning and announced the relocation of its headquarters to Nashville, ...

(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to five new employees as approved by the ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

JonesResearch analyst Catherine Novack initiated coverage of ProQR Therapeutics (PRQR) with a Buy rating and $11 price target The firm says ...

A dual-responsive hydrogel offers a breakthrough in osteoarthritis treatment by inhibiting neurovascularization and reducing ...

2018 saw a breakthrough in the field of RNA interference (RNAi), when the US FDA approved the first drug using this gene-silencing mechanism. Five years and five more approved drugs later ...

Apple Silicon chips have transformed attitudes toward ARM architecture, from being suitable mostly for power-efficient mobile devices to also ...